Reduce
Wasted Spend
Wasted Spend
Reach Instantly
Compliant Activation
ProReach AI™ helps marketers understand audience reach before launch so they can make better targeting decisions and reduce wasted spend.
Instantly generate HCP audience counts based on brand, therapeutic category, and channel.
See how much of your target audience you can actually reach before launch.
Identify the right balance of email, fax, direct mail, or omnichannel for stronger performance
Powered by AxisOne™ and deployed through PTM’s secure, controlled environment.
Build and validate your audience in minutes.
Enter your brand and therapeutic category
Choose email, fax, direct mail, or Triple Play
See reachable audience counts, estimated coverage, and channel opportunity.
Unlock deeper insights or launch with PTM.
Use ProReach AI™ when audience precision directly impacts campaign performance.
Build more precise campaigns across Canada’s full healthcare landscape.
Target physicians by specialty, therapeutic focus, and prescribing relevance.
Reach retail, hospital, and institutional pharmacists involved in treatment decisions.
Connect with nurses, educators, therapists, and other care influencers.
Target hospitals, clinics, institutions, and healthcare networks nationwide.
ProReach AI™ is PTM’s audience intelligence platform for Canadian pharma marketers. Powered by AxisOne™, it helps teams estimate reachable HCP audiences, compare channels, and identify coverage gaps before launch. Users enter a brand, therapeutic category, and channel, then receive real-time audience counts and reach estimates to guide smarter campaign planning and reduce wasted spend.
ProReach AI™ improves HCP targeting by showing who you can actually reach before budget is committed. It helps marketers size audiences, identify unreachable segments, and compare channel performance across email, fax, direct mail, or omnichannel. This leads to stronger targeting decisions, cleaner segmentation, and better campaign efficiency, especially for launches, adherence programs, and specialty brands.
Yes. ProReach AI™ is built on AxisOne™, PTM’s CASL-compliant Canadian HCP database. All audience insights are generated within PTM’s secure environment using consent-managed data and controlled deployment workflows. No raw email data is exposed, which helps reduce compliance risk while ensuring campaigns remain audit-ready, regulator-safe, and aligned with Canadian pharmaceutical marketing standards.
No. ProReach AI™ does not provide raw email lists or downloadable contact data. It is designed to deliver audience intelligence, reach estimates, and planning insights within PTM’s secure environment. This protects compliance, reduces deployment risk, and ensures all campaigns are executed using controlled, consent-managed workflows. Rep List Lease options are available separately for field sales planning.
After generating audience insights, teams can request a deeper ProReach Insights Report, or move directly into campaign planning with PTM. Most users start with audience validation and consultation, then use those insights to refine targeting, improve channel mix, and activate campaigns with greater confidence and less execution risk.
ProReach AI™ is most useful when audience precision affects performance. Teams use it for new product launches, line extensions, disease awareness, patient adherence programs, sales force targeting, and omnichannel planning. It is especially valuable when reach is unclear, channel mix needs validation, or teams want to reduce wasted spend before launch.
See your reachable audience, uncover missed opportunity, and build a smarter HCP campaign with ProReach AI™.